ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,916Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 807

$557K Total Retail Price of All Prescriptions

Rank: 87 out of 807

548 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 548 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 548 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 8,908 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 473 416 1 1
LEVOTHYROXINE SODIUM 451 409 2 3
FUROSEMIDE 389 380 3 6
ATENOLOL 387 368 4 7
LISINOPRIL 325 289 5 2
LOSARTAN POTASSIUM 283 250 6 14
OMEPRAZOLE 273 237 7 4
HYDROCODONE-ACETAMINOPHEN 223 195 S3 8 15
AMLODIPINE BESYLATE 220 198 9 5
HYDROCHLOROTHIAZIDE 196 181 10 9
PRAVASTATIN SODIUM 181 164 11 21
GABAPENTIN 171 153 12 16
METOPROLOL SUCCINATE 169 161 13 13
WARFARIN SODIUM 163 151 14 10
ZOLPIDEM TARTRATE 162 162 15 23
ATORVASTATIN CALCIUM 143 137 16 11
TRAMADOL HCL 140 132 17 19
POTASSIUM CHLORIDE 138 122 18 18
SERTRALINE HCL 135 119 19 22
PREDNISONE 132 122 20 24
METOPROLOL TARTRATE 131 122 21 8
ALENDRONATE SODIUM 123 119 22 20
CITALOPRAM HBR 105 102 23 17
METFORMIN HCL 99 77 24 12
DONEPEZIL HCL 82 82 25 31
FLUTICASONE PROPIONATE 80 69 26 30
CIPROFLOXACIN HCL 74 70 27 72
CRESTOR 73 67 28 32
PEN NEEDLE 73 59 28 63
LANTUS SOLOSTAR 70 60 30 42
ROPINIROLE HCL 69 69 31 95
ADACEL 69 62 31 92
GLIPIZIDE 68 63 33 58
ALLOPURINOL 68 68 33 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 61 33 28
ISOSORBIDE MONONITRATE ER 67 67 36 36
PANTOPRAZOLE SODIUM 66 64 37 44
RANITIDINE HCL 66 48 37 34
LOSARTAN-HYDROCHLOROTHIAZIDE 64 64 39 55
METFORMIN HCL ER 61 37 40 61
TRAZODONE HCL 60 55 41 25
CARVEDILOL 59 56 42 35
TRIAMTERENE-HCTZ 56 54 43 29
ADVAIR DISKUS 55 46 44 33
JANTOVEN 52 52 45 37
OXYCODONE HCL 52 50 S2 45 53
FLUOXETINE HCL 51 39 47 52
DIGOXIN 51 51 47 41
PAROXETINE HCL 50 44 49 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.